Alba Therapeutics Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Alba Therapeutics Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					         Alba Therapeutics Corporation - Pharmaceuticals & Healthcare - Deals and
                                     Alliances Profile
       Reference Code: GDPH124031D                                                                                                                     Publication Date: OCT 2012
      Company Overview                                                                                           Key Facts
      Alba Therapeutics Corporation (Alba) is a development stage pharmaceutical                                 Alba Therapeutics Corporation, Pharmaceuticals &
      company. It focuses on the discovery, development and marketing of therapeutics                            Healthcare, Key Facts
      for the treatment of celiac disease and inflammatory diseases. The company's                                Web Address              www.albatherapeutics.c
      technology is based on modifying disease state epithelial permeability using                                                         om
      compounds that influence the regulation of tight junctions in cell barriers in the body
                                                                                                                  Revenue (US$ million)              NA
      with applications in celiac disease, acute lung injury and asthma/COPD. The
                                                                                                                  Number of Employees                NA
      company partners with academic institutions and pharmaceutical companies for
                                                                                                                  GlobalData
      financial support, and enhancement of research, development, and manufacturing
      capabilities. Its partners include Cephalon, Inc.

      Financial Deals Landscape
        Alba Therapeutics Corporation, Pharmaceuticals & Healthcare,                        Alba Therapeutics Corporation, Pharmaceuticals &
        Deals by Type, 2006 to YTD 2012                                                     Healthcare, Deals By Year, 2006 to YTD 2012


                                                                                                                    1            1                                1
                                                                                                             1




                                                                                             No. of Deals

                                                                                                                                         0         0         0               0
                                                                                                             0
                                                                                                                   2006         2007   2008       2009   2010    2011       YTD
                                                                                                                                                                            2012

                                                                                            Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                            from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Alba Therapeutics Corporation, Pharmaceuticals &                                   Alba Therapeutics Corporation, Pharmaceuticals &
         Healthcare, Deals By Region, 2006 to YTD 2012                                      Healthcare, Deals By Therapy Area, 2006 to YTD 2012


                                     2                                                                       3
          No. of Deals




                                                                                             No. of Deals




                          2                                                                                                 3
                                                  1                                                          2
                          1
                                                                                                             1
                                                               0          0            0                                                     0           0              0
                          0                                                                                  0
                               North            Asia-     Europe        Middle    South                                 Immunol        Cardiova        Central   Pharmac
                               Americ           Pacific                  East      and                                    ogy           scular         Nervous    euticals
                                 a                                       and      Central                                                              System       and
                                                                        Africa    Americ                                                                         Healthcar
                                                                                    a                                                                                e

         Note: Deals include all announced pharmaceuticals & healthcare deals               Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                      from 2006 onwards, GlobalData


         Alba Therapeutics Corporation, Pharmaceuticals &                                   Alba Therapeutics Corporation, Pharmaceuticals &
         Healthcare, Licensing Deals by Year, 2006 to YTD 2012                              Healthcare, Licensing Deals by Phase, 2006 to YTD 2012


                                          1
                                                                                                                   0
                                                                                                             Marketed
                          1
                                                                                                                   0
                                                                                                            Approved
           No. of Deals




                                                                                                        Phase IV 0
                                                                                                         Phase III 0
                                                                                                         Phase II                                                                1
                                                                                                          Phase I 0
                                                                                                      Pre Clinical 0
                               0                   0       0        0         0    0
                          0                                                                                             0                                                   1
                              2006       2007    2008     2009     2010   2011    YTD
                                                                                  2012                                                           No. of Deals
                                                                                            Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals               from 2006 onwards, GlobalData
         from 2006 onwards, GlobalData

Alba Therapeutics Corporation - Pharmaceuticals & Healthcare -                                                                                           Reference Code: GDPH124031D
Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                           Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Alba Therapeutics Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 ................................................. 4
       Alba Therapeutics Corporation, Pharmaceuticals & Healthcare Deals By Type, 2006 to YTD 2012.................................................. 5
       Alba Therapeutics Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2006 to YTD 2012 ............................................. 6
       Alba Therapeutics Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2006 to YTD 2012 ................................... 7
       Alba Therapeutics Corporation, Pharmaceuticals & Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront
       Payment, 2006 to YTD 2012 .............................................................................................................................................................. 8
       Alba Therapeutics Corporation, Pharmaceuticals & Healthcare, Licensing Deals, Deals By Therapy Area Vs Deal Value Vs Upfront
       Payment, 2006 to YTD 2012 .............................................................................................................................................................. 9
       Alba Therapeutics Corporation, Pharmaceuticals & Healthcare, Licensing Deals, Deals By Phase Vs Deal Value Vs Upfront
       Payment, 2006 to YTD 2012 ............................................................................................................................................................ 10
       Alba Therapeutics Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2006 to YTD 2012 ............................................ 11
       Alba Therapeutics Corporation, Pharmaceuticals & Healthcare, Deal Details.................................................................................. 12
          Venture Financing......................................................................................................................................................................... 12
             Alba Therapeutics 
				
DOCUMENT INFO
Description: Alba Therapeutics Corporation (Alba) is a development stage pharmaceutical company. It focuses on the discovery, development and marketing of therapeutics for the treatment of celiac disease and inflammatory diseases. The company's technology is based on modifying disease state epithelial permeability using compounds that influence the regulation of tight junctions in cell barriers in the body with applications in celiac disease, acute lung injury and asthma/COPD. The company partners with academic institutions and pharmaceutical companies for financial support, and enhancement of research, development, and manufacturing capabilities. Its partners include Cephalon, Inc.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.